CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression

Hsiao‐Chi Tsai(China Medical University), Chih‐Hsin Tang(Asia University), Lijun Gan(Qinghai Red Cross Hospital), Chi‐Kuan Chen(Mackay Memorial Hospital), Chun‐Hao Tsai(China Medical University), Te‐Yang Huang(Mackay Memorial Hospital), Shih‐Chia Liu(Mackay Memorial Hospital), Yuan‐Li Huang(Asia University), Yi‐Chin Fong(China Medical University), An‐Chen Chang(Memorial Hospital)
Journal of Cellular Physiology
October 14, 2018
10.1002/jcp.27611
Cited by 26

Related Papers

CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
|Carcinogenesis|2014|149
Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression
|Journal of Hematology & Oncology|2017|102
Noggin Inhibits IL-1β and BMP-2 Expression, and Attenuates Cartilage Degeneration and Subchondral Bone Destruction in Experimental Osteoarthritis
|Cells|2020|97
CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling
|Cancer Letters|2017|87
MicroRNA-146a Decreases High Glucose/Thrombin-Induced Endothelial Inflammation by Inhibiting NAPDH Oxidase 4 Expression
|Mediators of Inflammation|2014|86